ObvioHealth’s decentralized study design and user-friendly app break down barriers to traditional GI research.
Learn more about our experience in GI clinical research. Speak with our clinical operations team today.
Recruitment & Onboarding
Recruitment is often a huge barrier to trial success, particularly for GI studies. ObvioHealth uses digital targeting methods to find untapped populations. We identify the online behaviors that point to people with a positive pre-disposition for a specific trial and, because our studies are virtual, we are not geographically tied to a site location. Data is collected through our proprietary app, giving participants more privacy in their responses.
Once recruited, we enroll participants through virtual prescreening/screening and e-consent. This eliminates the burdensome cost of site retention and staffing requirements, and often shortens the recruitment period.
The ObvioHealth platform and app incorporates multiple data capture technologies to adapt to the needs of any given trial. These include simple survey-type completion of questionnaires and diaries, image, video and audio capture and use of wearables. Complementary data collection methods ensure more robust data based on real world outcomes.
Symptoms of GI disorders can be physically uncomfortable, but also quite awkward to discuss with a doctor, leading to fear of embarrassment in face to face interactions. GI study subjects are generally more willing to contribute to research, knowing they can participate from the comfort and discretion of their homes without the burden of traveling to site visits.
Our platform makes it easy to trigger, track and manage products and payment of incentives. ObvioHealth can reimburse participants with the stipend program that is fully virtual. We ship any needed study supplies or devices directly to the participant’s home.
Medication Adherence & Adverse Events
An important advantage of ObvioHealth’s app is the real time remote monitoring of medication adherence and potential adverse events. Our escalating system of reminders and immediate AE/SAE detection make our studies safer, while also improving medication adherence.
ObvioHealth and GI Alliance Partner to Bring Better GI Care to Patients
ObvioHealth has partnered with GI Alliance, one of the nation's largest independent gastroenterology services organization to facilitate more efficient hybrid clinical trials. This collaboration will make research easier and safer for patients and provide better efficacy data for trial sponsors.Read Full Case Study
Evaluating Efficacy and GI Tolerance of Inulin Fiber Bars
A fortune 500 multinational food company wanted to understand clinical efficacy, GI tolerance, and consumer perception of four iterations of its inulin fiber bar. ObvioHealth virtually recruited, randomized, shipped and captured data across 4 samples in record time.
• 85% questionnaire compliance
• 92% retention
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.